Jennifer Thorne

Professor

19982019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jennifer Thorne is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Uveitis Medicine & Life Sciences
HIV Medicine & Life Sciences
Visual Acuity Medicine & Life Sciences
Acquired Immunodeficiency Syndrome Medicine & Life Sciences
Panuveitis Medicine & Life Sciences
Macular Edema Medicine & Life Sciences
Adrenal Cortex Hormones Medicine & Life Sciences
Cytomegalovirus Retinitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study

North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS, Apr 1 2019, In : The Lancet HIV. 6, 4, p. e240-e249

Research output: Contribution to journalArticle

Viremia
Non-Hodgkin's Lymphoma
Immunosuppression
Multicenter Studies
Canada

Billing of cataract surgery as complex versus routine for Medicare beneficiaries

Zafar, S., Wang, P., Srikumaran, D., D. Schein, O., Thorne, J., Makary, M. A. & Woreta, F. A., Jan 1 2019, (Accepted/In press) In : Journal of cataract and refractive surgery.

Research output: Contribution to journalArticle

Medicare
Cataract
Odds Ratio
Confidence Intervals
Medical Schools

Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases

SITE Cohort Research Group, Dec 1 2019, In : American journal of ophthalmology. 208, p. 68-75 8 p.

Research output: Contribution to journalArticle

Mycophenolic Acid
Eye Diseases
Methotrexate
Adrenal Cortex Hormones
Structural Models
End Stage Liver Disease
Chronic Kidney Failure
Canada
Cohort Studies
Myocardial Infarction

Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis

Luo, L., Yang, J., Oh, Y., Hartsock, M. J., Xia, S., Kim, Y. C., Ding, Z., Meng, T., Eberhart, C. G., Ensign-Hodges, L., Thorne, J., Stark, W. J., Duh, E. J., Xu, Q. & Hanes, J. S., Feb 28 2019, In : Journal of Controlled Release. 296, p. 68-80 13 p.

Research output: Contribution to journalArticle

dexamethasone 21-phosphate
Uveitis
Nanoparticles
Adrenal Cortex Hormones
Intravitreal Injections